糖尿病新世界
糖尿病新世界
당뇨병신세계
DIABETES NEW WORLD
2015年
8期
20-21
,共2页
2型糖尿病%甘精胰岛素联合口服药%治疗效果分析
2型糖尿病%甘精胰島素聯閤口服藥%治療效果分析
2형당뇨병%감정이도소연합구복약%치료효과분석
Type 2 diabetes%Glargine combined oral medication%Treatment effect analysis
目的:分析应用甘精胰岛素联合口服药治疗2型糖尿病临床效果。方法随机选取该院2013年11月—2014年11月期间收治的2型糖尿病患者100例作为研究对象,随机分为观察组和对照组,每组各50例,观察组行甘精胰岛素联合口服药治疗,对照组行预混胰岛素治疗,对比两组患者治疗效果以及并发症发生几率。结果经治疗后,两组患者空腹血糖水平以及餐后2 h血糖水平和治疗前相比,差异无统计学意义(P>0.05);观察组血糖达标时间、胰岛素用量明显低于对照组(P<0.05);观察组患者发生低血糖几率显著低于对照组(P<0.05)。结论应用甘精胰岛素联合口服药治疗2型糖尿病患者,效果显著,且并发症发生几率较低,值得在临床上推广。
目的:分析應用甘精胰島素聯閤口服藥治療2型糖尿病臨床效果。方法隨機選取該院2013年11月—2014年11月期間收治的2型糖尿病患者100例作為研究對象,隨機分為觀察組和對照組,每組各50例,觀察組行甘精胰島素聯閤口服藥治療,對照組行預混胰島素治療,對比兩組患者治療效果以及併髮癥髮生幾率。結果經治療後,兩組患者空腹血糖水平以及餐後2 h血糖水平和治療前相比,差異無統計學意義(P>0.05);觀察組血糖達標時間、胰島素用量明顯低于對照組(P<0.05);觀察組患者髮生低血糖幾率顯著低于對照組(P<0.05)。結論應用甘精胰島素聯閤口服藥治療2型糖尿病患者,效果顯著,且併髮癥髮生幾率較低,值得在臨床上推廣。
목적:분석응용감정이도소연합구복약치료2형당뇨병림상효과。방법수궤선취해원2013년11월—2014년11월기간수치적2형당뇨병환자100례작위연구대상,수궤분위관찰조화대조조,매조각50례,관찰조행감정이도소연합구복약치료,대조조행예혼이도소치료,대비량조환자치료효과이급병발증발생궤솔。결과경치료후,량조환자공복혈당수평이급찬후2 h혈당수평화치료전상비,차이무통계학의의(P>0.05);관찰조혈당체표시간、이도소용량명현저우대조조(P<0.05);관찰조환자발생저혈당궤솔현저저우대조조(P<0.05)。결론응용감정이도소연합구복약치료2형당뇨병환자,효과현저,차병발증발생궤솔교저,치득재림상상추엄。
[Abstrac]Objective To analyze the application of insulin glaring combined with oral treatment of type 2 diabetes clinical effect. Methods Patients with type 2 diabetes were randomly selected in our hospital in November 2013-2014 11 100 cases during the month of the study, were randomly divided into two groups and the control group, 50 patients in the observation group glaring joint line oral treatment, the control group were premixed insulin therapy, comparing two groups of patients as well as treatment and the occurrence probability of occurrence. Results After treatment, patients were fasting blood glucose levels as well as pre-2h postprandial blood glucose levels and treatment compared to no significant difference (P>0.05);observation group time blood glucose, insulin dose was significantly lower than the control group (P<0.05 );the chances of hypoglycemia in patients in the observation group was significantly lower than the control group (P<0.05). Conclusion Combined oral insulin glaring treatment of type 2 diabetes, the effect is significant, and the low probability of complications, should be promoted in clinical practice.